These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8536870)

  • 1. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
    Serfaty L; Chazouillères O; Pawlotsky JM; Andreani T; Pellet C; Poupon R
    Gastroenterology; 1996 Jan; 110(1):291-5. PubMed ID: 8536870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    Hepatogastroenterology; 1999; 46(26):1094-9. PubMed ID: 10370673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
    Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
    J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
    Wright TL; Combs C; Kim M; Ferrell L; Bacchetti P; Ascher N; Roberts J; Wilber J; Sheridan P; Urdea M
    Hepatology; 1994 Oct; 20(4 Pt 1):773-9. PubMed ID: 7927216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Darthuy F; Rémiré J; Métreau JM; Zafrani ES; Duval J; Dhumeaux D
    J Infect Dis; 1996 Jul; 174(1):1-7. PubMed ID: 8655978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of hepatitis C: patients with normal aminotransferase levels.
    Marcellin P; Lévy S; Erlinger S
    Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
    Silverman AL; Piquette DL; Filipiak CL; Neill JS; Bayati N; Gordon SC
    Am J Gastroenterol; 1997 Oct; 92(10):1793-5. PubMed ID: 9382038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.
    Bini EJ; Mehandru S
    Aliment Pharmacol Ther; 2006 Mar; 23(6):777-85. PubMed ID: 16556180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion.
    Hosoda K; Yokosuka O; Kato N; Ito Y; Ohto M; Omata M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():115-7. PubMed ID: 8395437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.
    Brillanti S; Garson J; Foli M; Whitby K; Deaville R; Masci C; Miglioli M; Barbara L
    Gastroenterology; 1994 Sep; 107(3):812-7. PubMed ID: 7521308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis.
    Rossini A; Ravaggi A; Biasi L; Agostinelli E; Bercich L; Gazzola GB; Callea F; Radaeli E; Cariani E
    Hepatology; 1997 Oct; 26(4):1012-7. PubMed ID: 9328328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.
    Sim H; Yim C; Krajden M; Heathcote J
    Am J Gastroenterol; 1998 Jan; 93(1):39-43. PubMed ID: 9448171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
    Yokosuka O; Kato N; Hosoda K; Ito Y; Imazeki F; Ohto M; Omata M
    Gut; 1995 Nov; 37(5):721-6. PubMed ID: 8549952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.
    Lau JY; Mizokami M; Ohno T; Diamond DA; Kniffen J; Davis GL
    Lancet; 1993 Nov; 342(8881):1208-9. PubMed ID: 7901531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study.
    Sangiovanni A; Morales R; Spinzi G; Rumi M; Casiraghi A; Ceriani R; Colombo E; Fossati M; Prada A; Tavani E; Minoli G
    Hepatology; 1998 Mar; 27(3):853-6. PubMed ID: 9500717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity.
    Tran A; Longo F; Ouzan D; Bianchi D; Pradier C; Saint-Paul MC; Sattonnet C; Laffont C; Dantin S; Piche T; Benzaken S; Rampal P
    Scand J Gastroenterol; 2000 Apr; 35(4):433-7. PubMed ID: 10831269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-viral therapy for occult hepatitis C virus infection.
    Pardo M; López-Alcorocho JM; Castillo I; Rodríguez-Iñigo E; Perez-Mota A; Carreño V
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1153-9. PubMed ID: 16611276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.